Precisia Clinical Risk Analytics

Welcome to Precisia Clinical Risk Analytics! Precisia is dedicated to making a meaningful impact on healthcare outcomes at the intersection of innovation, technology and precision population health, with its unique capability for identifying risk-based medical need. With a strong NHS heritage and global healthcare footprint, we are uniquely positioned to enable global collaborations that yield local impact. Our collaborations deliver precision at scale. We bridge the gap between Life Sciences and health systems, driving advancements that improve patients’ lives. Our vision is to deepen understanding of real unmet need and drivers of variation and enable: • Life Science innovators to evidence the impact of their innovations with trusted clinical outcomes and financial benefits data • Cross-sector collaborations that improve population health and reduce inequity and • R&D targeting real unmet need, delivering outcomes and reduced inequity. Powered by globally unique C2-Ai clinical risk-adjustment, Precisia provides insights into real unmet health needs and health inequity, that inform product development and demonstrate impact of innovation. Precisia® Outcome Analytics provides near-real-time evaluation of patient outcomes after deployment of a new technology that, combined with broader health economic analysis, provides evidence of the clinical and financial impact of specific solutions. Using our award-winning technology*, Life Sciences organisations can: • gain unparalleled perspectives on individual patients and population groups • develop solutions that support diverse population needs • more effectively signpost product development to address real unmet need • increase uptake of innovation to improve patients’ lives • more accurately identify and signpost for clinical trials and • deliver definitive real-world outcomes from clinical investigations and research more quickly - reducing time and waste and improving overall ROI in R&D. *Powered by www.c2-ai.com